5% Lidocaine medicated plaster for the treatment of postherpetic neuralgia in elderly patients ─ subgroup analyses from three European clinical trials.

CONCLUSIONS: The 5% lidocaine medicated plaster provided pain relief and marked reductions in allodynia severity in elderly PHN patients with an excellent safety profile under short- and long-term treatment supporting the addition of the plaster to the treatment armamentarium for this age group. STUDY LIMITATIONS: All analyzed study phases were open-label and lacking a placebo control group. PMID: 28035844 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28035844?dopt=Abstract

Source: Current Medical Research and Opinion - January 1, 2017 Category: Research Tags: Curr Med Res Opin Source Type: research